Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell

DOI 10.1016/j.ccell.2017.05.005

Cited by (1,000)

Items 201–300 of 1,000

Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation
Sara Badodi, Nicola Pomella, Xinyu Zhang, Gabriel Rosser, John Whittingham, Maria Victoria Niklison-Chirou, Yau Mun Lim, Sebastian Brandner, Gillian M. Morrison, Steven M. Pollard et al. · 2021 · Nature Communications
Pediatric Neuro-Oncology
Fatema Malbari · 2021 · Neurologic Clinics
Developmental basis of SHH medulloblastoma heterogeneity
Maxwell P. Gold, Winnie Ong, Andrew M. Masteller, David R. Ghasemi, Julie Galindo, Noel R. Park, Nhan C. Huynh, Aneesh Donde, Veronika I. Pister, Raul A. Saurez et al. · 2024 · Nature Communications
Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma
Abhirami Visvanathan, Olivier Saulnier, Chuan Chen, Parthiv Haldipur, Wilda Orisme, Alberto Delaidelli, Seungmin Shin, Jake Millman, Andrew Bryant, Namal Abeysundara et al. · 2024 · Cell
Inactivation of Citron Kinase Inhibits Medulloblastoma Progression by Inducing Apoptosis and Cell Senescence
Gianmarco Pallavicini, Francesco Sgrò, Francesca Garello, Mattia Falcone, Valeria Bitonto, Gaia Elena Berto, Federico T. Bianchi, Marta Gai, Alessandra M.A. Chiotto, Miriam Filippi et al. · 2018 · Cancer Research
A Hierarchical Clustering algorithm based on Silhouette Index for cancer subtype discovery from genomic data
N. Nidheesh, K. A. Abdul Nazeer, P. M. Ameer · 2019 · Neural Computing and Applications
The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas
Keisuke Katsushima, Bongyong Lee, Haritha Kunhiraman, Cuncong Zhong, Rabi Murad, Jun Yin, Ben Liu, Alexandra Garancher, Ignacio González-Gómez, Hector L. Monforte et al. · 2020 · Neuro-Oncology
Chloride intracellular channel 1 cooperates with potassium channel EAG2 to promote medulloblastoma growth
Michelle A. Francisco, Siyi Wanggou, Jerry J. Fan, Weifan Dong, Xin Chen, Ali Momin, Namal Abeysundara, Hyun-Kee Min, Jade Chan, Rochelle F. McAdam et al. · 2020 · The Journal of Experimental Medicine
Advances in Targeted Therapies for Pediatric Brain Tumors
Timothy Mueller, Ana Guerreiro Stücklin, Andreas Postlmayr, Sarah M. Metzger, Nicolas U. Gerber, Cassie Kline, Michael Andreas Grotzer, Javad Nazarian, Sabine Mueller · 2020 · Current Treatment Options in Neurology
CNS embryonal tumours: WHO 2016 and beyond
Jessica C. Pickles, Cynthia E Hawkins, Torsten Pietsch, Thomas S. Jacques · 2017 · Neuropathology and Applied Neurobiology
A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma
Jezabel Rodríguez‐Blanco, Bin Li, Jun Long, Chen Shen, Fan Yang, Darren Orton, Sara Collins, Noriyuki Kasahara, Nagi G. Ayad, Heather J. McCrea et al. · 2018 · Clinical Cancer Research
Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death
Laura M. Kallay, Havva Keskin, Alexandra Ross, Manali Rupji, Olivia A. Moody, Xin Wang, Guanguan Li, Taukir Ahmed, Farjana Rashid, Michael Rajesh Stephen et al. · 2019 · Journal of Neuro-Oncology
A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma
Ekaterina Pak, Ethan L. MacKenzie, Xuesong Zhao, Maria F. Pazyra‐Murphy, Paul M.C. Park, Lei Wu, Daniel L Shaw, Emily Addleson, Suzanne Cayer, Begoña G-C Lopez et al. · 2019 · Neuro-Oncology
A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis
Han Zou, Bradley Poore, Emily E. Brown, Jieqi Qian, Bin Xie, Evridiki Asimakidou, Vladislav Razskazovskiy, Deanna Ayrapetian, Vaibhav Sharma, Shunjin Xia et al. · 2023 · Nature Cell Biology
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibition
Veronica Ferrucci, Pasqualino De Antonellis, Francesco Paolo Pennino, Fatemeh Asadzadeh, Antonella Virgilio, Donatella Montanaro, Aldo Galeone, Iolanda Boffa, Ida Pisano, Iolanda Scognamiglio et al. · 2018 · Brain
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
Evelyn Susanto, Ana Marín Navarro, Leilei Zhou, Anders Sundström, Niek F. H. N. van Bree, Marina Stantic, Mohsen Moslem, Jignesh K. Tailor, Jonne Rietdijk, Verónica Zubillaga et al. · 2020 · Proceedings of the National Academy of Sciences
High impact of miRNA-4521 on FOXM1 expression in medulloblastoma
Daniel Senfter, Mahzeiar Samadaei, Robert M. Mader, Johannes Gojo, Andreas Peyrl, Georg Krupitza, Marcel Kool, Martin Sill, Christine Haberler, Gerda Ricken et al. · 2019 · Cell Death and Disease
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
Nagendra K. Chaturvedi, Sidharth Mahapatra, Varun Kesherwani, Matthew J. Kling, Mamta Shukla, Sutapa Ray, Ranjana Kumari Kanchan, Naveenkumar Perumal, Timothy R. McGuire, John Graham Sharp et al. · 2019 · BMC Cancer
Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience
Filippo Spreafico, Andrea Ferrari, Maurizio Mascarin, Paola Collini, Carlo Morosi, Davide Biasoni, Veronica Biassoni, Elisabetta Schiavello, Lorenza Gandola, Giovanna Gattuso et al. · 2019 · Cancer and Metastasis Reviews
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma
Paola Infante, Alessio Malfanti, Deborah Quaglio, Silvia Balducci, Sara De Martin, Francesca Bufalieri, Francesca Mastrotto, Irene Basili, Mariangela Garofalo, Ludovica Lospinoso Severini et al. · 2020 · Cancer Letters
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
Marije J. Voskamp, Shuang Li, Kim Robin van Daalen, Sandra Crnko, Toine ten Broeke, Niels Bovenschen · 2021 · Cancers
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors
Jasmin Bartl, Marco Zanini, Flavia Bernardi, Antoine Forget, Lena Blümel, Julie Talbot, Daniel J. Picard, Nan Qin, Gabriele Cancila, Qingsong Gao et al. · 2022 · Nature Communications
Posterior fossa tumors in children: current insights
Cleiton Formentin, Andrei Fernandes Joaquim, Enrico Ghizoni · 2023 · European Journal of Pediatrics
Mouse medulloblastoma driven by CRISPR activation of cellular Myc
Baohan Thi Vo, Jin Ah Kwon, Chunliang Li, David Finkelstein, Beisi Xu, Brent A. Orr, Charles J. Sherr, Martine F. Roussel · 2018 · Scientific Reports
Genetics of Common Pediatric Brain Tumors
Fatema Malbari, Holly Lindsay · 2019 · Pediatric Neurology
The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway
Stefania Scicchitano, Marco Giordano, Valeria Lucchino, Ylenia Montalcini, Emanuela Chiarella, Annamaria Aloisio, Bruna Codispoti, Pietro Zoppoli, Valentina Melocchi, Fabrizio Bianchi et al. · 2019 · Cell Death and Disease
Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples
Colleen E. D’Arcy, Liana Figueiredo Nobre, Anthony Arnaldo, Vijay Ramaswamy, Michael D. Taylor, Lili‐Naz Hazrati, Cynthia E Hawkins · 2020 · Journal of Neuropathology & Experimental Neurology
Methylation‐based algorithms for diagnosis: experience from neuro‐oncology
Jessica C. Pickles, T. J. Stone, Thomas S. Jacques · 2020 · The Journal of Pathology
Network Diffusion Promotes the Integrative Analysis of Multiple Omics
Noemi Di Nanni, Matteo Bersanelli, Luciano Milanesi, Ettore Mosca · 2020 · Frontiers in Genetics
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Han Zou, Brad Poore, Alberto Broniscer, Ian F. Pollack, Baoli Hu · 2020 · Cancers
Imaging of brain tumors in children: the basics—a narrative review
Lucas Lopes Resende, Cesar Alves · 2021 · Translational Pediatrics
The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
Mariana Medeiros, Marina Ferreira Cândido, Elvis Terci Valera, María Sol Brassesco · 2021 · Cellular and Molecular Life Sciences
Regulation of early cerebellar development
Elijah David Lowenstein, Ke Cui, Luis Rodrigo Hernandez-Miranda · 2022 · FEBS Journal
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
Nan Qin, Eunice Paisana, Maike Langini, Daniel J. Picard, Bastian Malzkorn, Carlos Custódia, Rita Cascão, Frauke-Dorothee Meyer, Lena Blümel, Sarah Göbbels et al. · 2022 · Neuro-Oncology
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
Lisa Liang, Ludivine Coudière-Morrison, Nazanin Tatari, Margaret Stromecki, Agnes L. Fresnoza, Christopher J. Porter, Marc R. Del Bigio, Cynthia E Hawkins, Jennifer Ai-wen Chan, Timothy Charles Ryken et al. · 2018 · Cancer Research
The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells
Mor Varon, Tal Levy, Gal Mazor, Hila Ben-David, Ran Marciano, Yakov Krelin, Manu Prasad, Moshe Elkabets, David Pauck, Ulvi Ahmadov et al. · 2019 · International Journal of Cancer
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Mary Jane Lim-Fat, Julie Bennett, Quinn T. Ostrom, Mehdi Touat, Enrico Franceschi, Jessica D. Schulte, Ranjit S. Bindra, Jason Fangusaro, Girish Dhall, James Christopher Nicholson et al. · 2024 · Neuro-Oncology
Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI
Bridget A. Kennis, Keith A. Michel, William Benjamin Brugmann, Álvaro Macedo Laureano, Rong-Hua Tao, Srinivas S. Somanchi, Samuel A. Einstein, Javiera B Bravo-Alegria, Shinji Maegawa, Andrew Wahba et al. · 2019 · Journal of Neuro-Oncology
HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma
Mariane da Cunha Jaeger, Eduarda Chiesa Ghisleni, Paula Schoproni Cardoso, Marialva Siniglaglia, Tiago Falcón, Andre Tesainer Brunetto, Algemir Lunardi Brunetto, Caroline Brunetto de Farias, Michael D. Taylor, Carolina Nör et al. · 2020 · Journal of Molecular Neuroscience
Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies
Jean-Paul Bryant, John D. Heiss, Yeshavanth Banasavadi‐Siddegowda · 2021 · Cells
Recent advances in the molecular understanding of medulloblastoma
Yusuke Funakoshi, Yuriko Sugihara, Atsuhito Uneda, Takuma Nakashima, Hiromichi Suzuki · 2022 · Cancer Science
PTCH1 -mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis
Max J. van Essen, Elizabeth J. Apsley, Joey Riepsaame, Ruijie Xu, Paul A. Northcott, Sally A. Cowley, John Jacob, Esther B. E. Becker · 2024 · Disease Models & Mechanisms
Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures
Yan-Ran Wang, Pengcheng Wang, Zihan Yan, Quan Zhou, Fatma Güntürkün, Peng Li, Yanshen Hu, Wei Emma Wu, Kankan Zhao, Michael Zhang et al. · 2024 · Cancer Cell
Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities
Pengfei Diao, Yibin Dai, An Wang, Xiaoxuan Bu, Ziyu Wang, Jin Li, Yaping Wu, Hongbing Jiang, Yanling Wang, Jie Cheng · 2024 · Cancer Research
Medulloblastoma: experimental models and reality
Julia E. Neumann, Fredrik J. Swartling, Ulrich Schüller · 2017 · Acta Neuropathologica
Transcriptional repressor REST drives lineage stage–specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma
Tara Dobson, Rong-Hua Tao, Jyothishmathi Swaminathan, Shinji Maegawa, Shavali Shaik, Javiera B Bravo-Alegria, Ajay Sharma, Bridget A. Kennis, Yanwen Yang, Keri Callegari et al. · 2019 · Science Signaling
Immune cell infiltration and cytokine secretion analysis reveal a non-inflammatory microenvironment of medulloblastoma
Shuo Diao, Chunyu Gu, Hongwei Zhang, Chunjiang Yu · 2020 · Oncology Letters
Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma
Feng‐Chi Chang, Tai‐Tong Wong, Kuo-Sheng Wu, Chia‐Feng Lu, Ting-Wei Weng, Muh‐Lii Liang, Chih‐Chun Wu, Wan‐Yuo Guo, Cheng‐Yu Chen, Kevin Li‐Chun Hsieh · 2021 · PLoS ONE
The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential
Niek F. H. N. van Bree, Margareta Wilhelm · 2022 · Cancers
Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
Matthew J Pun, Drew W. Pratt, Patricia R. Nano, Piyush K. Joshi, Li Jiang, Bernhard Englinger, Arvind U.K. Rao, Marcin P. Cieslik, Arul M. Chinnaiyan, Kenneth Aldape et al. · 2023 · Acta Neuropathologica Communications
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Ugo Testa, Germana Castelli, Elvira Pelosi · 2018 · Medical Sciences
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Harish Shrikrishna Bharambe, Raikamal Paul, Pooja Panwalkar, Rakesh Jalali, Sridhar Epari, Tejpal Gupta, Aliasgar V. Moiyadi, Prakash M. Shetty, Sadaf Kazi, Akash Deogharkar et al. · 2019 · Acta Neuropathologica Communications
New Approaches in Targeted Therapy for Medulloblastoma in Children
HENRIETTA MAIER, Tina Dalianis, Ourania N. Kostopoulou · 2021 · Anticancer Research
DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profiles
Sepehr Safaei, Malte Mohme, Judith Niesen, Ulrich Schüller, Michael Ludwig Bockmayr · 2021 · OncoImmunology
Epigenetic regulation in medulloblastoma
Jiaqing Yi, Jiang I. Wu · 2017 · Molecular and Cellular Neuroscience
Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation
Eduardo Cambruzzi · 2018 · Child s Nervous System
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2
Eleonora Spiombi, Annapaola Angrisani, Simone Fonte, Giuseppina De Feudis, Francesca Fabretti, Danilo Cucchi, Mariapaola Izzo, Paola Infante, Evelina Miele, Agnese Pò et al. · 2019 · Oncogenesis
KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis
Reeti Mayur Sanghrajka, Richard P. Koche, Hector Medrano, Salsabiel El Nagar, Daniel N. Stephen, Zhimin Lao, Nermin Sumru Bayin, Kai Ge, Alexandra L. Joyner · 2023 · iScience
Heterogeneity and tumoral origin of medulloblastoma in the single-cell era
Hui Sheng, Haotai Li, Han Zeng, Bin Zhang, Lu Yu, Xixi Liu, Zhongwen Xu, Jing Zhang, Liguo Zhang · 2024 · Oncogene
Rare Primary Central Nervous System Tumors in Adults: An Overview
Enrico Franceschi, Didier Frappaz, Roberta Rudà, Peter Hau, Matthias Preusser, Caroline Houillier, Giuseppe Lombardi, Sofia Asioli, Caroline Dehais, Franck Bielle et al. · 2020 · Frontiers in Oncology
Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier
Laura A. Genovesi, Simon G. Puttick, Amanda Millar, Marija Kojic, Pengxiang Ji, Anne K. Lagendijk, Caterina Brighi, Claudine S. Bonder, Christelle Adolphe, Brandon J. Wainwright · 2020 · Neuro-Oncology
Channeling Force in the Brain: Mechanosensitive Ion Channels Choreograph Mechanics and Malignancies
Ali Momin, Shahrzad Bahrampour, Hyun-Kee Min, Xin Chen, Xian Wang, Yu Sun, Xi Huang · 2021 · Trends in Pharmacological Sciences
Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation
Heyu Song, Shaoyan Xi, Yingling Chen, Suravi Pramanik, Jiping Zeng, Shrabasti Roychoudhury, Hannah L. Harris, Anum Akbar, Salma Elhag, Donald W. Coulter et al. · 2021 · Cancer Letters
Extracellular Matrix Proteome Remodeling in Human Glioblastoma and Medulloblastoma
Marina Trombetta-Lima, Lívia Rosa-Fernandes, Cláudia Blanes Angeli, Isabele Fattori Moretti, Yollanda Edwirges Moreira Franco, Adaliana Sorg Mousessian, Alda Wakamatsu, Antônio Marcondes Lerário, Sueli Mieko Oba‐Shinjo, Carlos Augusto Pasqualucci et al. · 2021 · Journal of Proteome Research
A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
Soledad Gómez‐González, Alícia Garrido-Garcia, Laura Garcia-Gerique, Isadora Versiani de Lemos, Mariona Suñol, Carmen de Torres, Marta Kulis, Sara Pérez‐Jaume, Angel Montero Carcaboso, Betty Luu et al. · 2018 · Clinical Cancer Research
Molecular classification improves therapeutic options for infants and young children with medulloblastoma
Bagchi, Aditi, Dhanda, Sandeep K., Dunphy, Paige, Sioson, Edgar, Robinson, Giles W. · 2023 · Journal of the National Comprehensive Cancer Network
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group
Tab Cooney, Holly Lindsay, Sarah E. S. Leary, Robert J. Wechsler‐Reya · 2022 · Neoplasia
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, Letícia Ferro Leal, Flávia Escremim de Paula, Iara Viana Vidigal Santana, Gustavo Ramos Teixeira, Fabiano Pinto Saggioro, Luciano Neder, Carlos Roberto de Almeida Junior et al. · 2023 · Frontiers in Immunology
Epigenetic pathways and plasticity in brain tumors
Robert K. Suter, Jezabel Rodríguez‐Blanco, Nagi G. Ayad · 2020 · Neurobiology of Disease
Ion Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk
Jerry J. Fan, Xi Huang · 2020 · Reviews of physiology, biochemistry and pharmacology
Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses
Jack J. Brzezinski, Sanaa Choufani, Rodrigo L. P. Romao, Cheryl T. Shuman, Haiying Chen, Joanna Cunanan, Darius Bägli, Ronald M. Grant, Armando José Lorenzo, Rosanna Weksberg · 2020 · British Journal of Cancer
Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
Clara Andradas, Jacob Byrne, Mani Kuchibhotla, Mathew Ancliffe, Anya C. Jones, Brooke Carline, Hilary L. Hii, Alexandra Truong, Lisa C. D. Storer, Timothy A. Ritzmann et al. · 2021 · Cancers
Infantile Brain Tumors: A Review of Literature and Future Perspectives
Valeria De Simone, Daniela Rizzo, Alessandro Cocciolo, Anna Maria Caroleo, Andrea Carai, Angela Mastronuzzi, Assunta Tornesello · 2021 · Diagnostics
Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
Daniel Rickert, Jasmin Bartl, Daniel J. Picard, Flavia Bernardi, Nan Qin, Marta Lovino, Stéphanie Puget, Frauke-Dorothee Meyer, Idriss Mahoungou Koumba, Thomas Beez et al. · 2021 · Acta Neuropathologica
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Anna Borgenvik, Karl O. Holmberg, Sara Bolin, Miao Zhao, Vasil Savov, Gabriela Rosén, Sonja Hutter, Alexandra Garancher, Aldwin Suryo Rahmanto, Tobias Bergström et al. · 2022 · Cancer Research
MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells
Dimitra Tripolitsioti, Karthiga Santhana Kumar, Anuja Neve, Jessica Migliavacca, Charles Capdeville, Elisabeth Jane Rushing, Min Ma, Noriyuki Kijima, Ashish Sharma, Martin N. Pruschy et al. · 2018 · Oncotarget
A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology
Julia Lorenz, Tanja Rothhammer-Hampl, Saida Zoubaa, Elisabeth Bumes, Tobias Pukrop, Oliver Kölbl, Selim Corbacioglu, Nils Ole Schmidt, Martin Andreas Proescholdt, Peter Hau et al. · 2020 · Acta Neuropathologica Communications
Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases
Tran Ngoc Anh Nguyen, Hong-Toan Lai, Romain Fernandes, Filippo Gustavo Dall’Olio, Camille Blériot, Tâp Ha‐Duong, Catherine Brenner · 2025 · Cell Communication and Signaling
Put away your microscopes: the ependymoma molecular era has begun
Stephen C. Mack, Michael D. Taylor · 2017 · Current Opinion in Oncology
Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide
Ryan Takeo Nitta, Sara Bolin, Emily Joan Luo, David E. Solow-Cordero, Peyman Samghabadi, Teresa Purzner, Parvir S. Aujla, Ginikachi Nwagbo, Yoon‐Jae Cho, Gordon Li · 2019 · Oncogene
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second‐generation subtypes
Debbie Hicks, Gholamreza Rafiee, Ed C. Schwalbe, C. I. Howell, Janet C. Lindsey, R. M. Hill, Amanda J Smith, Peter Adidharma, C. Steel, S. Richardson et al. · 2020 · Neuropathology and Applied Neurobiology
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
Rebecca M. Hill, Sabine L. A. Plasschaert, Beate Timmermann, Christelle Dufour, Kristian Aquilina, Shivaram Avula, Laura Donovan, Maarten Hans Lequin, Torsten Pietsch, Ulrich Wilhelm Thomale et al. · 2021 · Cancers
Establishing an In Vitro 3D Spheroid Model to Study Medulloblastoma Drug Response and Tumor Dissemination
Sophie J. Roper, Beth Coyle · 2022 · Current Protocols
Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma
Shenglan Li, Jinyi Chen, Yaqiong Fan, Ce Wang, Can Wang, Xiaohong Zheng, Feng Chen, Wenbin Li · 2022 · Signal Transduction and Targeted Therapy
Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta‐analysis
Likun Cui, Dongdong Feng, Chaofan Zhu, Qiuyu Li, Wenqing Li, Baoguo Liu · 2022 · Laryngoscope Investigative Otolaryngology
Adult Medulloblastoma: Updates on Current Management and Future Perspectives
Enrico Franceschi, Caterina Giannini, Julia Furtner, Kristian W. Pajtler, Sofia Asioli, Raphael G Guzman, Clemens Seidel, Lidia Gatto, Peter Hau · 2022 · Cancers
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas
Tobias Goschzik, Martin Mynarek, Evelyn Doerner, Alina Schenk, Isabel Spier, Monika Warmuth‐Metz, Brigitte Bison, Denise Obrecht, Nina Struve, Rolf‐Dieter Kortmann et al. · 2022 · Acta Neuropathologica
Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models
Elysse K. Morris, Sheena M. Daignault, Samantha J. Stehbens, Laura A. Genovesi, Anne K. Lagendijk · 2023 · Frontiers in Oncology
Characterization of a novel OTX 2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
Margaret Stromecki, Nazanin Tatari, Ludivine Coudière Morrison, Ravinder Kaur, Jamie L. Zagozewski, Gareth Palidwor, Vijay Ramaswamy, Patryk Skowron, Matthias Wölfl, Till Milde et al. · 2018 · Molecular Oncology
A simplified approach using Taqman low-density array for medulloblastoma subgrouping
Gustavo Alencastro Veiga Cruzeiro, Karina Bezerra Salomão, Carlos Alberto Oliveira de Biagi, Martin Baumgartner, Dominik Sturm, Régia Caroline Peixoto Lira, Taciani de Almeida Magalhães, Mirella Baroni, Vanessa S. Silveira, Fabiano Pinto Saggioro et al. · 2019 · Acta Neuropathologica Communications
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Shweta Godbole, Hannah Voß, Antonia Gocke, Simon Schlumbohm, Yannis Schumann, Bojia Peng, Martin Mynarek, Stefan Rutkowski, Matthias Dottermusch, Mario M. Dorostkar et al. · 2024 · Nature Communications
Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Reference Network
Simon Bailey, Sandra A. Jacobs, Maria Kourti, Maura Massimino, Nicolás André, François Doz, Christelle Dufour, Sabina Vennarini, Laëtitia Padovani, Kristian Aquilina et al. · 2024 · EJC Paediatric Oncology
Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis
Fu Qiang Zhao, Jing Zhang, Peng Li, Qiangyi Zhou, Shun Zhang, Chi Zhao, Bo Wang, Zhijun Yang, Chunde Li, Pinan Liu · 2018 · Journal of Neuro-Oncology
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
Zaili Luo, Yunfei Liao, Dazhuan Xin, Kalen Berry, Sean Ogurek, Xinran Dong, Hao Li, Jianzhong Yu, Feng Zhang, Ron Han et al. · 2023 · Nature Communications
Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome
Anna S Kolodziejczak, Léa Guerrini‐Rousseau, Julien Masliah‐Planchon, Jonas Ecker, Florian Selt, Martin Mynarek, Denise Obrecht, Martin Sill, Robert J. Autry, Eric Stutheit-Zhao et al. · 2023 · Neuro-Oncology
Combined functional genomic and chemical screens identify SETD8 as a therapeutic target in MYC-driven medulloblastoma
Bethany L. Veo, Etienne P. Danis, Angela M. Pierce, Ismail Sola, Dong Wang, Nicholas K. Foreman, Jian Jun Jin, Anqi Ma, Natalie Julie Serkova, Sujatha Venkataraman et al. · 2019 · JCI Insight
Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres
Kavneet Kaur, Prerana Jha, Pankaj Pathak, Vaishali S. Suri, Mehar Chand Sharma, Ajay Kumar Garg, Ashish Suri, Chitra Sarkar · 2019 · Journal of Neuro-Oncology
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Jack Goddard, Jemma Castle, Emily Southworth, Anya Fletcher, Stephen Crosier, Idoia Martín‐Guerrero, Miguel García-Ariza, Aurora Navajas, Julien Masliah‐Planchon, Franck Bourdeaut et al. · 2023 · Acta Neuropathologica
Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience
Derek S. Tsang, Nasim Sarhan, Vijay Ramaswamy, Liana Figueiredo Nobre, Ryan Yee, Michael D. Taylor, Cynthia E Hawkins, Ute Katharina Bartels, Annie Huang, Uri Y. Tabori et al. · 2019 · Journal of Neuro-Oncology
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
David Bakhshinyan, Ashley Adile, Jeff Liu, William D. Gwynne, Yujin Suk, Stefan Custers, Ian Burns, Mohini Singh, Nicole M. McFarlane, Minomi Subapanditha et al. · 2021 · Science Advances